(0.47%) 5 041.77 points
(0.48%) 38 085 points
(0.92%) 15 749 points
(-0.49%) $78.61
(5.02%) $2.03
(-0.17%) $2 307.00
(0.05%) $26.76
(0.65%) $961.15
(0.12%) $0.934
(0.06%) $11.04
(0.15%) $0.800
(0.12%) $93.37
Live Chart Being Loaded With Signals
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery; lens exchange surgery comprising the monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services...
Stats | |
---|---|
Šios dienos apimtis | 185 000 |
Vidutinė apimtis | 60 958.00 |
Rinkos kapitalizacija | 1.85B |
EPS | HKD0 ( 2024-03-26 ) |
Last Dividend | HKD0.0511 ( 2023-09-11 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 16.91 |
ATR14 | HKD0.0330 (0.59%) |
Euroeyes International Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Euroeyes International Finansinės ataskaitos
Annual | 2022 |
Pajamos: | HKD610.29M |
Bruto pelnas: | HKD270.84M (44.38 %) |
EPS: | HKD0.270 |
FY | 2022 |
Pajamos: | HKD610.29M |
Bruto pelnas: | HKD270.84M (44.38 %) |
EPS: | HKD0.270 |
FY | 2021 |
Pajamos: | HKD632.93M |
Bruto pelnas: | HKD312.55M (49.38 %) |
EPS: | HKD0.410 |
FY | 2020 |
Pajamos: | HKD473.82M |
Bruto pelnas: | HKD214.10M (45.19 %) |
EPS: | HKD0.199 |
Financial Reports:
No articles found.
Euroeyes International Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0627 (N/A) |
HKD0.0511 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0299 | 2021-05-25 |
Last Dividend | HKD0.0511 | 2023-09-11 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | HKD0.243 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.29 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.71 | |
Div. Directional Score | 9.18 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2778.HK | Ex Dividend Junior | 2023-09-15 | Semi-Annually | 0 | 0.00% | |
1449.HK | Ex Dividend Junior | 2023-05-24 | Insufficient data to determine frequency | 0 | 0.00% | |
0533.HK | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
6896.HK | Ex Dividend Junior | 2023-06-16 | Annually | 0 | 0.00% | |
1982.HK | Ex Dividend Junior | 2023-07-06 | Annually | 0 | 0.00% | |
1051.HK | Ex Dividend Junior | 2023-06-26 | Sporadic | 0 | 0.00% | |
0124.HK | No Dividend Player | 2023-10-06 | Sporadic | 0 | 0.00% | |
3396.HK | No Dividend Player | 2023-07-03 | Annually | 0 | 0.00% | |
1599.HK | Ex Dividend Junior | 2023-05-31 | Annually | 0 | 0.00% | |
0639.HK | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.172 | 1.500 | 6.56 | 9.83 | [0 - 0.5] |
returnOnAssetsTTM | 0.0702 | 1.200 | 7.66 | 9.19 | [0 - 0.3] |
returnOnEquityTTM | 0.111 | 1.500 | 9.88 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.190 | -1.000 | 8.10 | -8.10 | [0 - 1] |
currentRatioTTM | 5.22 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 5.04 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 4.82 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.219 | -1.500 | 6.35 | -9.52 | [0 - 0.6] |
interestCoverageTTM | 14.90 | 1.000 | 5.59 | 5.59 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.615 | 2.00 | 9.79 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.413 | 2.00 | 9.79 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.335 | -1.500 | 8.66 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.441 | 1.000 | 5.98 | 5.98 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.243 | 1.000 | 7.13 | 7.13 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.558 | 1.000 | 8.01 | 8.01 | [0.2 - 2] |
assetTurnoverTTM | 0.407 | 0.800 | -0.617 | -0.494 | [0.5 - 2] |
Total Score | 12.64 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 15.58 | 1.000 | 8.53 | 0 | [1 - 100] |
returnOnEquityTTM | 0.111 | 2.50 | 9.92 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.413 | 2.00 | 9.86 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.07 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.615 | 2.00 | 9.79 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.190 | 1.500 | 8.10 | -8.10 | [0 - 1] |
pegRatioTTM | -0.139 | 1.500 | -4.26 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.300 | 1.000 | 5.00 | 0 | [0.1 - 0.5] |
Total Score | 5.71 |
Euroeyes International
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery; lens exchange surgery comprising the monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. Its correction services are used for the treatment of myopia, high myopia, presbyopia, and cataract. The company serves mid-to-high income level customers, who primarily seek surgery to treat their myopia; and above 45 years of age, who primarily seek surgery to treat their presbyopia or cataract. It operates consultation centers and clinics for eye treatment and LASIK centers; and sells pharmaceutical products. The company is also involved in the trading of eye clinic equipment and lenses; and ophthalmic equipment renting and spaces operating activities. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.